icometrix
icometrix.com
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
icometrix is a Belgian medical technology company founded in 2011 and based in Leuven. Its software analyses brain magnetic resonance images to quantify changes in multiple sclerosis, dementia and brain injury. The products are cleared in Europe and the United States and used by hospitals worldwide.
News
MSAA and icometrix Partner to Expand MRI Access and Equity in MS Care
June 15, 2026 - New Jersey, USA / Leuven, Belgium - The Multiple Sclerosis Association of America (MSAA), the leading nonprofit improving lives for all people living with MS, in partnership with icometrix (now a GE HealthCare company), a global leader in
Read more
Report
A New Era in Alzheimer's Disease Care: Transforming Neurology with AI
The Importance of Timely Diagnosis When disease-modifying therapies transformed multiple sclerosis care, brain MRI scans became central to annual patient monitoring. Standardized MRI protocols and clinical guidelines emerged. Teams adapted. Technology hel
Read more
Report
Multiple sclerosis: the EU turns to artificial intelligence for increasingly predictive and personalised therapies
Using artificial intelligence (AI) to process a sufficiently large amount of data and build a harmonised database , with the goal of making the clinical management of multiple sclerosis more predictive and tailored to each patient , ultimately improving q
Read more
Report
icometrix collaborates with AstraZeneca and MENACTRIMS on new AI-driven initiative aiming to improve NMOSD diagnosis across the Middle East & Africa
AI-Powered MRI Analysis Expected to Enhance Early Detection of NMOSD A Collaborative Effort to Improve Diagnosis DUBAI, UAE - ( ARAB NEWSWIRE ) AstraZeneca has announced a strategic regional collaboration with the Middle East North Africa Committee for Tr
Read more
Report
Embedding imaging AI in your Alzheimer's clinical workflow: From diagnosis to ARIA monitoring
The field of Alzheimer's disease care is evolving rapidly . The approval of disease-modifying therapies have necessitated earlier...
Read more
Report
Pro access
Upgrade to see all 25 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.